SCHEMBL21596683

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL29829576	0.90	CCR4 (0.56)	CCR4EDNRA
	SCHEMBL21596685	0.90	CCR4 (0.56)	CCR4EDNRA
	SCHEMBL21596698	0.86	CCR4 (0.53)	CCR4EDNRACCR5
	SCHEMBL30286576	0.83	CCR4 (0.46)	CCR4
	SCHEMBL20339186	0.83	CCR4 (0.46)	CCR4
	SCHEMBL30729959	0.82	CCR4 (0.45)	CCR4EDNRA
	SCHEMBL26980258	0.82	CCR4 (0.45)	CCR4EDNRA
	SCHEMBL1732316	0.82	CCR4 (1.00)	CCR4EDNRACCR5
	SCHEMBL1733073	0.82	CCR4 (1.00)	CCR4EDNRACCR5
	SCHEMBL29903833	0.81	CCR4 (0.43)	CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.